-+ 0.00%
-+ 0.00%
-+ 0.00%

Wedbush Maintains Outperform on Dianthus Therapeutics, Raises Price Target to $122

Benzinga·08/05/2026 13:22:09
Listen to the news
Wedbush analyst Laura Chico maintains Dianthus Therapeutics (NASDAQ:DNTH) with a Outperform and raises the price target from $105 to $122.